Literature DB >> 23512317

Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months.

Bruno Scheller1, Dieter Fischer, Yvonne P Clever, Franz X Kleber, Ulrich Speck, Michael Böhm, Bodo Cremers.   

Abstract

We report a male with a coronary bifurcation lesion in the mid circumflex artery (CX). After predilatation, the lesion was treated with two drug-coated balloons (DCB). Primary success in the posterolateral branch was good; however the CX lesion had a residual stenosis including a non-flow-limiting type A dissection. After 6 months, angiography showed slight lumen enlargement in both branches of the bifurcation. Intravascular ultrasound identified about 35 % atherosclerotic plaque load within the inner area of the bifurcation but more than 50 % concentric atherosclerotic plaque burden in the vessel areas proximal and distal to the DCB-treated area.

Entities:  

Mesh:

Year:  2013        PMID: 23512317     DOI: 10.1007/s00392-013-0556-3

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  19 in total

1.  Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter.

Authors:  Bruno Scheller; Christoph Hehrlein; Wolfgang Bocksch; Wolfgang Rutsch; Dariush Haghi; Ulrich Dietz; Michael Böhm; Ulrich Speck
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

2.  One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.

Authors:  Gaku Nakazawa; Marc Vorpahl; Aloke V Finn; Jagat Narula; Renu Virmani
Journal:  JACC Cardiovasc Imaging       Date:  2009-05

3.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Authors:  Michael Joner; Aloke V Finn; Andrew Farb; Erik K Mont; Frank D Kolodgie; Elena Ladich; Robert Kutys; Kristi Skorija; Herman K Gold; Renu Virmani
Journal:  J Am Coll Cardiol       Date:  2006-05-05       Impact factor: 24.094

4.  Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial.

Authors:  Roberto Diletti; Vasim Farooq; Chrysafios Girasis; Christos Bourantas; Yoshinobu Onuma; Jung Ho Heo; Bill D Gogas; Robert-Jan van Geuns; Evelyn Regar; Bernard de Bruyne; Dariusz Dudek; Leif Thuesen; Bernard Chevalier; Dougal McClean; Stephan Windecker; Robert J Whitbourn; Pieter Smits; Jacques Koolen; Ian Meredith; Xiaolin Li; Karine Miquel-Hebert; Susan Veldhof; Hector M Garcia-Garcia; John A Ormiston; Patrick W Serruys
Journal:  Heart       Date:  2012-10-31       Impact factor: 5.994

5.  A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study.

Authors:  Harald Rittger; Johannes Brachmann; Anil-M Sinha; Matthias Waliszewski; Marc Ohlow; Andreas Brugger; Holger Thiele; Ralf Birkemeyer; Volkhard Kurowski; Ole-A Breithardt; Martin Schmidt; Stefan Zimmermann; Sandra Lonke; Moritz von Cranach; The-Vinh Nguyen; Werner G Daniel; Jochen Wöhrle
Journal:  J Am Coll Cardiol       Date:  2012-02-29       Impact factor: 24.094

6.  Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease.

Authors:  Jochen Wöhrle; Ralf Birkemeyer; Sinisa Markovic; The-Vinh Nguyen; Anil Sinha; Tomislav Miljak; Jochen Spiess; Wolfgang Rottbauer; Harald Rittger
Journal:  Heart       Date:  2011-05-26       Impact factor: 5.994

7.  Paclitaxel-eluting balloon angioplasty and cobalt-chromium stents versus conventional angioplasty and paclitaxel-eluting stents in the treatment of native coronary artery stenoses in patients with diabetes mellitus.

Authors:  Rosli Mohd Ali; Ralf Degenhardt; Robaayah Zambahari; Damras Tresukosol; Wan Azman Wan Ahmad; Haizal bin Haron Kamar; Sim Kui-Hian; Tiong Kiam Ong; Omar bin Ismail; Safari bin Elis; Wasan Udychalerm; Hanns Ackermann; Michael Boxberger; Martin Unverdorben
Journal:  EuroIntervention       Date:  2011-05       Impact factor: 6.534

8.  SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study.

Authors:  Jochen Wöhrle; Mariusz Zadura; Sven Möbius-Winkler; Matthias Leschke; Christian Opitz; Waqas Ahmed; Paul Barragan; Jean-Philippe Simon; Graham Cassel; Bruno Scheller
Journal:  J Am Coll Cardiol       Date:  2012-10-03       Impact factor: 24.094

9.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

10.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.

Authors:  U Sigwart; J Puel; V Mirkovitch; F Joffre; L Kappenberger
Journal:  N Engl J Med       Date:  1987-03-19       Impact factor: 91.245

View more
  7 in total

1.  Plaque modification and stabilization after paclitaxel-coated balloon treatment for de novo coronary lesions.

Authors:  Ae-Young Her; Eun-Seok Shin; Ju-Hyun Chung; Yong Hoon Kim; Scot Garg; Joo Myung Lee; Joon-Hyung Doh; Chang-Wook Nam; Bon-Kwon Koo
Journal:  Heart Vessels       Date:  2019-01-30       Impact factor: 2.037

2.  Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.

Authors:  Franz X Kleber; Antonia Schulz; Matthias Waliszewski; Telse Hauschild; Michael Böhm; Ulrich Dietz; Bodo Cremers; Bruno Scheller; Yvonne P Clever
Journal:  Clin Res Cardiol       Date:  2014-10-28       Impact factor: 5.460

3.  A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease.

Authors:  Atsushi Funatsu; Shigeru Nakamura; Naoto Inoue; Shinsuke Nanto; Masato Nakamura; Masashi Iwabuchi; Kenji Ando; Ryuta Asano; Seiji Habara; Shigeru Saito; Ken Kozuma; Kazuaki Mitsudo
Journal:  Clin Res Cardiol       Date:  2017-06-06       Impact factor: 5.460

4.  Treatment of coronary de novo bifurcation lesions with DCB only strategy.

Authors:  Antonia Schulz; Telse Hauschild; Franz X Kleber
Journal:  Clin Res Cardiol       Date:  2014-02-14       Impact factor: 5.460

5.  Treatment of In-Stent Restenosis by Excimer Laser Coronary Atherectomy and Drug-Coated Balloon: Serial Assessment with Optical Coherence Tomography.

Authors:  Toru Miyazaki; Takashi Ashikaga; Taku Fukushima; Yu Hatano; Taro Sasaoka; Ken Kurihara; Yuichi Ono; Shigeo Shimizu; Kenichiro Otomo; Kenzo Hirao
Journal:  J Interv Cardiol       Date:  2019-04-18       Impact factor: 2.279

6.  Anatomical and Physiological Changes after Paclitaxel-Coated Balloon for Atherosclerotic De Novo Coronary Lesions: Serial IVUS-VH and FFR Study.

Authors:  Soe Hee Ann; Gillian Balbir Singh; Kyung Hun Lim; Bon-Kwon Koo; Eun-Seok Shin
Journal:  PLoS One       Date:  2016-01-29       Impact factor: 3.240

7.  Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.

Authors:  Tudor C Poerner; Corinna Duderstadt; Björn Goebel; Daniel Kretzschmar; Hans R Figulla; Sylvia Otto
Journal:  Clin Res Cardiol       Date:  2016-07-05       Impact factor: 5.460

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.